Literature DB >> 22503040

Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis.

Pradeep Tyagi1, Kim Killinger, Vikas Tyagi, Jayabalan Nirmal, Michael Chancellor, Kenneth M Peters.   

Abstract

PURPOSE: Based on basic research findings an increase in chemokines and cytokines (CXCL-1 and 10, nerve growth factor and interleukin-6) is considered responsible for inflammation and afferent sensitization. In this cross-sectional study we tested the hypothesis that select chemokines are increased in the urine of patients with ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome.
MATERIALS AND METHODS: Midstream urinary specimens were collected from 10 patients with ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome, respectively, and from 10 asymptomatic controls. Urinary levels of 7 cytokines were measured by a human cytokine/chemokine assay. Nerve growth factor was measured by enzyme-linked immunosorbent assay.
RESULTS: Urinary levels of most chemokines/cytokines were tenfold to 100-fold lower in asymptomatic controls vs patients with ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome. Univariate comparison of 8 tested proteins in the ulcerative vs nonulcerative groups revealed a significant fivefold to twentyfold increase in CXCL-10 and 1, interleukin-6 and nerve growth factor (ANOVA p<0.001).
CONCLUSIONS: Differential expression of chemokines in ulcerative and nonulcerative subtypes of interstitial cystitis/painful bladder syndrome suggests differences in paracrine signaling between the 2 entities.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503040      PMCID: PMC3674640          DOI: 10.1016/j.juro.2012.01.034

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

1.  Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.

Authors:  Shahrokh F Shariat; Kazumasa Matsumoto; Roberto Casella; Weiguo Jian; Seth P Lerner
Journal:  Eur Urol       Date:  2005-03-08       Impact factor: 20.096

Review 2.  Vascular endothelial growth factor and vascular homeostasis.

Authors:  Alon Lazarus; Eli Keshet
Journal:  Proc Am Thorac Soc       Date:  2011-11

3.  Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome.

Authors:  Verónica Sánchez-Freire; Maxime G Blanchard; Fiona C Burkhard; Thomas M Kessler; Stephan Kellenberger; Katia Monastyrskaya
Journal:  J Urol       Date:  2011-08-19       Impact factor: 7.450

4.  Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease.

Authors:  Ralph Peeker; Magnus Fall
Journal:  J Urol       Date:  2002-06       Impact factor: 7.450

5.  Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

Authors:  Guillermo Pérez DE Lema; Holger Maier; Elena Nieto; Volker Vielhauer; Bruno Luckow; Francisco Mampaso; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

6.  MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome.

Authors:  Veronica Sanchez Freire; Fiona C Burkhard; Thomas M Kessler; Annette Kuhn; Annette Draeger; Katia Monastyrskaya
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis.

Authors:  Teruyuki Ogawa; Toshiki Homma; Yasuhiko Igawa; Satoshi Seki; Osamu Ishizuka; Tetsuya Imamura; Satoshi Akahane; Yukio Homma; Osamu Nishizawa
Journal:  J Urol       Date:  2010-01-22       Impact factor: 7.450

Review 8.  Regulation of chemokine activity by posttranslational modification.

Authors:  Anneleen Mortier; Jo Van Damme; Paul Proost
Journal:  Pharmacol Ther       Date:  2008-08-28       Impact factor: 12.310

9.  Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients.

Authors:  Katerina M Antoniou; Nikolaos Tzanakis; Eleni G Tzortzaki; Katerina Malagari; Anastassios V Koutsopoulos; Michael Alexandrakis; Athol U Wells; Nikolaos M Siafakas
Journal:  Pulm Pharmacol Ther       Date:  2008-07-02       Impact factor: 3.410

10.  The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study.

Authors:  P M Hanno; J R Landis; Y Matthews-Cook; J Kusek; L Nyberg
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  37 in total

Review 1.  Advances in intravesical therapy for urinary tract disorders.

Authors:  Pradeep Tyagi; Mahendra Kashyap; Harvey Hensley; Naoki Yoshimura
Journal:  Expert Opin Drug Deliv       Date:  2015-10-19       Impact factor: 6.648

2.  Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.

Authors:  Anthony T Corcoran; Naoki Yoshimura; Vikas Tyagi; Bruce Jacobs; Wendy Leng; Pradeep Tyagi
Journal:  World J Urol       Date:  2012-03-24       Impact factor: 4.226

3.  Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.

Authors:  Pradeep Tyagi; Saundra S Motley; Mahendra Kashyap; Subrata Pore; Jeffrey Gingrich; Zhou Wang; Naoki Yoshimura; Jay H Fowke
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

4.  Biomarkers for interstitial cystitis/painful bladder syndrome.

Authors:  Shilpa Argade; Christopher Chermansky; Pradeep Tyagi
Journal:  Womens Health (Lond)       Date:  2015-12-23

5.  Association of inflammaging (inflammation + aging) with higher prevalence of OAB in elderly population.

Authors:  Pradeep Tyagi; Vikas Tyagi; Xianggui Qu; Hsin-Tzu Lin; Hann-Chorng Kuo; Yao-Chi Chuang; Michael Chancellor
Journal:  Int Urol Nephrol       Date:  2013-12-10       Impact factor: 2.370

6.  Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.

Authors:  C Symeonidis; S Androudi; I Georgalas; A Tzamalis; N Chalvatzis; T Rotsos; E Souliou; E Diza; S A Dimitrakos
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

7.  Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder.

Authors:  Mahendra Kashyap; Naoki Kawamorita; Vikas Tyagi; Yoshio Sugino; Michael Chancellor; Naoki Yoshimura; Pradeep Tyagi
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

8.  [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Authors:  D Jocham; G Froehlich; F Sandig; A Ziegler
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

9.  Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.

Authors:  Akira Furuta; Tokunori Yamamoto; Yasuyuki Suzuki; Momokazu Gotoh; Shin Egawa; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2018-01-25       Impact factor: 2.894

Review 10.  Influence of polyunsaturated fatty acids on urologic inflammation.

Authors:  Seetha M Tamma; Barbara Shorter; Khai-Lee Toh; Robert Moldwin; Barbara Gordon
Journal:  Int Urol Nephrol       Date:  2015-09-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.